Search
Search Results
##search.searchResults.foundPlural##
-
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3529PDF: 2096HTML: 7585 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4648Suppl. Files: 1266PDF: 1164Html: 322 -
COMPREHENSIVE REVIEW OF GENETIC AND EPIGENETICS REGULATION OF FETAL HEMOGLOBIN IN β-HEMOGLOBINOPATHIES: FROM MOLECULAR MECHANISMS TO CLINICAL APPLICATIONS HbF Genetics in Anemia
1001PDF: 708HTML: 147 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5544PDF: 1423HTML: 2884Cover letter: 250 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
5235PDF: 1378HTML: 1941Untitled: 235Untitled: 218 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3957PDF: 1679HTML: 8258Randi Fig: 234 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2334PDF: 1712HTML: 736 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2504PDF: 1966HTML: 188 -
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1545PDF: 633HTML: 250 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2121PDF: 834HTML: 733Table1: patient's characteristics: 239Table 2: profile of each patient: 234 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
1141PDF: 770HTML: 7884 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1949PDF: 812HTML: 581 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1446PDF: 504HTML: 18637Figure 1: 207Figure 2: 191Figure 3: 206Figure 4: 239Figure 5: 212 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2715PDF: 877HTML: 5393 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3316PDF: 1205HTML: 1696Untitled: 226Untitled: 228Untitled: 215 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3604PDF: 862HTML: 3034Figure 1a and 1b: 201Figure 2: 211Figure 3: 218Figure 4: 209Figure 5: 205Tables 1-5: 185 -
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2988PDF: 1237HTML: 11434 -
-
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1850PDF: 1396HTML: 670 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
13011PDF: 1770HTML: 4370Cover letter: 270Figure 1: 285 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5948PDF: 1611HTML: 1678Untitled: 284 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3421PDF: 1110HTML: 2564 -
TYROSINE KINASE INHIBITORS AND INTERFERON
3022PDF: 1517HTML: 3105Cover Letter: 266 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3226PDF: 1086HTML: 3241 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2668PDF: 1270HTML: 1095 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1272PDF: 819HTML: 1543Figure 1: 261Figure 2: 266 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
2075PDF: 856HTML: 621 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
2157PDF: 491HTML: 248







